Anticancer and Antimicrobial Activity Evaluation of Cowpea-Porous-Starch-Formulated Silver Nanoparticles

Figure 4

Antimicrobial efficacy of porous-starch-mediated AgNPs and against (a) E. coli, (b) K. pneumonia, (c) L. monocytogenes, and (d) S. aureus bacterial strains after exposure to different concentrations of AgNPs. Porous starch extract only (10 Molar) served as a negative control, and antibiotic ciprofloxacin (10 Molar) served as a positive control.

(a)

(b)

(c)

(d)